Comment
doi: 10.7326/M17-0907.
Epub 2017 Apr 25.
Making Do With What We Have
Affiliations
- PMID: 28437798
- DOI: 10.7326/M17-0907
Item in Clipboard
Comment
Making Do With What We Have
Ann Intern Med.
.
No abstract available
Comment on
-
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.Ann Intern Med. 2017 Jun 6;166(11):792-798. doi: 10.7326/M17-0377. Epub 2017 Apr 25. Ann Intern Med. 2017. PMID: 28437794 Review.
Similar articles
-
Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.Gastroenterology. 2017 Sep;153(3):626-631. doi: 10.1053/j.gastro.2017.07.025. Epub 2017 Jul 27. Gastroenterology. 2017. PMID: 28757271 No abstract available.
-
Ribavirin and chronic hepatitis C infection.FDA Consum. 2001 Sep-Oct;35(5):3. FDA Consum. 2001. PMID: 11697089 No abstract available.
-
A major advance in treating hepatitis C.Johns Hopkins Med Lett Health After 50. 2011 Dec;23(10):6. Johns Hopkins Med Lett Health After 50. 2011. PMID: 22216468 No abstract available.
-
Hepatitis C: current and future therapies.Mt Sinai J Med. 2008 Aug;75(4):405-14. doi: 10.1002/msj.20060. Mt Sinai J Med. 2008. PMID: 18729159 Review. No abstract available.
-
Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System.J Neuroophthalmol. 2016 Jun;36(2):221-2. doi: 10.1097/WNO.0000000000000336. J Neuroophthalmol. 2016. PMID: 26963573 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
